Glowing dye could replace radioactive tracers in breast cancer surgery

NCT ID NCT07311278

First seen Jan 10, 2026 · Last updated May 23, 2026 · Updated 16 times

Summary

This study tests a new method using a fluorescent dye called indocyanine green (ICG) to find sentinel lymph nodes in breast cancer patients. The current method uses a radioactive tracer that has limited availability and exposes patients to radiation. About 493 women with early-stage breast cancer will take part to see if ICG works just as well. If successful, this could make the procedure safer and more widely available.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Antoni van Leeuwenhoek Ziekenhuis

    Amsterdam, Netherlands

  • Bernhoven Ziekenhuis

    Uden, Netherlands

  • Erasmus Medisch Centrum

    Rotterdam, Netherlands

  • FlevoZiekenhuis

    Almere Stad, Netherlands

  • HagaZiekenhuis

    The Hague, Netherlands

  • Isala Ziekenhuis

    Zwolle, Netherlands

  • Jeroen Bosch Ziekenhuis

    's-Hertogenbosch, Netherlands

  • Maastricht Universitair Medisch Centrum

    Maastricht, Netherlands

  • Ospedale Pederzoli

    Peschiera del Garda, Italy

  • Reinier de Graaf Gasthuis

    Delft, Netherlands

  • Van Weel-Bethesda Ziekenhuis

    Dirksland, Netherlands

Conditions

Explore the condition pages connected to this study.